CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-12 | Schuyler Kevin Director | Other acquisition · Warrant to purchase common stock | +192,600 | 192,600 | ||
| 2018-11-12 | Schuyler Kevin Director | Other acquisition · Warrant to purchase common stock | +192,600 | 192,600 | ||
| 2018-11-12 | Schuyler Kevin Director | Other disposition · Warrant to purchase units | −120,000 | 0 | ||
| 2018-11-12 | Schuyler Kevin Director | Other acquisition · Warrant to purchase common stock | +120,000 | 120,000 | ||
| 2018-11-12 | Schuyler Kevin Director | Other acquisition · Warrant to purchase common stock | +120,000 | 120,000 | ||
| 2018-11-12 | Schuyler Kevin Director | Other disposition · Warrant to purchase units | −162,200 | 0 | ||
| 2018-11-12 | Schuyler Kevin Director | Other acquisition · Warrant to purchase common stock | +162,200 | 162,200 | ||
| 2018-11-12 | Schuyler Kevin Director | Other acquisition · Warrant to purchase common stock | +162,200 | 162,200 | ||
| 2018-11-12 | Newman James W. Jr. Director | Other disposition · Warrant to purchase units | −20,000 | 0 | ||
| 2018-11-12 | Newman James W. Jr. Director | Other acquisition · Warrant to purchase common stock | +20,000 | 20,000 | ||
| 2018-11-12 | Newman James W. Jr. Director | Other acquisition · Warrant to purchase common stock | +20,000 | 20,000 | ||
| 2018-11-12 | Newman James W. Jr. Director | Other disposition · Warrant to purchase units | −92,000 | 0 | ||
| 2018-11-12 | Newman James W. Jr. Director | Other acquisition · Warrant to purchase common stock | +92,000 | 92,000 | ||
| 2018-11-12 | Newman James W. Jr. Director | Other acquisition · Warrant to purchase common stock | +92,000 | 92,000 | ||
| 2018-11-12 | Stilley William B. III Chief Executive Officer | Other disposition · Warrant to purchase units | −36,800 | 0 | ||
| 2018-11-12 | Stilley William B. III Chief Executive Officer | Other acquisition · Warrant to purchase common stock | +36,800 | 36,800 | ||
| 2018-11-12 | Stilley William B. III Chief Executive Officer | Other acquisition · Warrant to purchase common stock | +36,800 | 36,800 | ||
| 2018-11-12 | Johnson Bankole A. Director | Other disposition · Warrant to purchase units | −17,600 | 0 | ||
| 2018-11-12 | Johnson Bankole A. Director | Other acquisition · Warrant to purchase common stock | +17,600 | 17,600 | ||
| 2018-11-12 | Johnson Bankole A. Director | Other acquisition · Warrant to purchase common stock | +17,600 | 17,600 |
Page 8 of 10 · 190 trades